ScoreWhy is Brooks Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.42%
- Poor long term growth as Net Sales has grown by an annual rate of 4.36% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -3.69
2
Below par performance in long term as well as near term
- Along with generating -54.54% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Brooks Lab. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Brooks Lab.
-54.54%
-0.92
59.15%
Sensex
7.97%
0.69
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.36%
EBIT Growth (5y)
24.94%
EBIT to Interest (avg)
-2.37
Debt to EBITDA (avg)
3.19
Net Debt to Equity (avg)
0.06
Sales to Capital Employed (avg)
0.83
Tax Ratio
0.83%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.47%
ROCE (avg)
-11.80%
ROE (avg)
2.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
9
Industry P/E
32
Price to Book Value
1.73
EV to EBIT
32.56
EV to EBITDA
26.15
EV to Capital Employed
1.69
EV to Sales
2.33
PEG Ratio
0.05
Dividend Yield
NA
ROCE (Latest)
5.90%
ROE (Latest)
12.08%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend19What is working for the Company
ROCE(HY)
Highest at 12.36%
PBT LESS OI(Q)
At Rs 5.37 cr has Grown at 66.6% (vs previous 4Q average
PAT(Q)
At Rs 5.50 cr has Grown at 57.5% (vs previous 4Q average
-6What is not working for the Company
NET SALES(Q)
Lowest at Rs 16.57 cr
PBDIT(Q)
Lowest at Rs 0.73 cr.
OPERATING PROFIT TO NET SALES (Q)
Lowest at 4.41%
Loading Valuation Snapshot...
Here's what is working for Brooks Lab.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 5.37 cr has Grown at 66.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 3.22 CrMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 5.50 cr has Grown at 57.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 3.49 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Here's what is not working for Brooks Lab.
Net Sales - Quarterly
At Rs 16.57 cr has Fallen at -28.6% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 23.20 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Net Sales - Quarterly
Lowest at Rs 16.57 cr
in the last five quartersMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs 0.73 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Lowest at 4.41%
in the last five quartersMOJO Watch
Company's efficiency has deteriorated
Operating Profit to Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
